Register
Why register?
- Download your favorite videos
- Build & share playlists with friends
- Get updates on new videos & podcasts
Registation Options:

Login


You can also
Forgot your password?
Biotech: Collaboration vs. Competition in Developing Affymax February 26, 2003
Gordon Ringold    |   Surromed
Entrepreneurial Thought Leader Lectures
Description
Ringold talks about the decision to move away from being a technology based company at Affymax to applying the technology to pharma because of the relatively small life of a leading technology. Because of lack on internal infrastructure, they decided to sell the company and put it into the hands of a bigger company that had the infrastructure and expertise to use the technology. After a global search, Glaxo bought Affymax, he says.

Statistics
Loading statistics data please wait...